2-Amino-4-Fluorobenzothiazole

2-Amino-4-Fluorobenzothiazole


    • Product Name 2-Amino-4-Fluorobenzothiazole
    • Alias 2-amino-4-fluorobenzo[d]thiazole
    • Einecs 257-413-0
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    394365

    Chemical Formula C7H5FN2S
    Molar Mass 168.19 g/mol
    Appearance Solid (usually a powder)
    Physical State At Room Temp Solid
    Melting Point 156 - 160 °C (reported range)
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in some organic solvents like DMSO, DMF
    Odor Odorless or very faint odor
    Color Off - white to light yellow

    As an accredited 2-Amino-4-Fluorobenzothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 2 - Amino - 4 - Fluorobenzothiazole packaged in a sealed, labeled bottle.
    Shipping 2 - Amino - 4 - Fluorobenzothiazole is shipped in sealed, corrosion - resistant containers. Packing ensures protection from moisture and external contaminants. Shipment follows strict chemical transportation regulations for safe delivery.
    Storage 2 - Amino - 4 - Fluorobenzothiazole should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Store it separately from oxidizing agents and incompatible substances. The storage area should be well - ventilated to minimize the risk of vapor accumulation.
    Application of 2-Amino-4-Fluorobenzothiazole

    In sulfur-accelerated vulcanization of EPDM compounds processed on intermeshing twin-screw extruders with L/D ≥ 48:1, the partial replacement of conventional sulfenamide accelerators (CBS or TBBS) by 2-Amino-4-Fluorobenzothiazole displaces the scorch time plateau by 2.5–3.0 minutes at 135 °C as recorded on a MDR 2000 rheometer per ASTM D5289-19a. In a standard formulation comprising 100 phr EPDM (ethylene content 55%, ENB 5.5%), 50 phr N550 carbon black, 5 phr ZnO, 1 phr stearic acid, and 2 phr rhombic sulfur, the introduction of AFBT at 0.8–1.5 phr in place of 0.4–0.7 phr CBS extends Mooney scorch (MS-t5, 125 °C, ISO 289-1:2015) from a baseline of 18 min to 24–28 min, simultaneously shifting the activation energy of crosslink formation (calculated by the Kissinger method from DSC non-isothermal curing exotherms) upward by approximately 8–12 kJ/mol. Production-scale experience on a Ø 70 mm co-rotating twin-screw line—operated at screw speed 220 rpm, barrel zones 80/90/100/110 °C, and equipped with a gear pump and 200-mesh screen pack—reveals that AFBT-loaded compounds exhibit a 15–20% increase in head pressure relative to CBS-only loads when the fluoro content exceeds 1.2 phr, attributable to transient melt-state association of the aromatic amine with filler-bound silanol groups. This rheological signature requires recalibration of the auto-thermal regulation loop. After strip-fed cold-feed extrusion and underwater pelletizing, injection molding into automotive turbocharger charge-air cooler hoses demands a clamp force margin ≥ 15% above the calculated projected area requirement to accommodate the delayed viscosity rise. The finished hose meets the ASTM D2000 M2BG710 classification, with tensile strength ≥ 10 MPa (ISO 37:2017), elongation at break ≥ 300%, and compression set (22 h/125 °C) below 25% (ISO 815-1:2019). Regulatory conformance integrates Regulation (EC) No 1907/2006 (REACH) Annex XVII restrictions on PAH content, FDA 21 CFR §177.2600 for repeated-use rubber articles in dry food contact, and the limits for 2-aminobenzothiazole migration of ≤ 0.15 mg/kg food simulant in EU 10/2011 (Annex II, specific migration limit for non-listed substances). Process boundary: AFBT should not be combined with peroxide-coagent cure systems because the primary aromatic amine quenches alkoxy radicals, yielding a severe undercure (Δ torque < 2 dNm on MDR). Outdoor storage of uncured AFBT-containing compounds requires wrapping in aluminum-laminated barrier film at RH > 60% to prevent pre-crosslinking catalyzed by ammonia released from slow ambient hydrolysis of the fluorinated heterocycle.

    MDR cure characteristics at 160 °C for AFBT-loaded EPDM (base compound 100 phr EPDM, 50 phr N550, 5 phr ZnO, 1 phr stearic acid, 2 phr sulfur)ASTM D5289-19a
    AFBT (phr)CBS (phr)ML (dNm)MH (dNm)ts2 (min)t90 (min)Tan δ at MH
    0.80.41.814.23.18.40.038
    1.00.51.915.03.59.10.035
    1.20.62.115.84.210.30.032
    1.50.72.316.45.012.00.030

    What Limits the Regio-selectivity in Fungicidal Benzothiazole Carboxamide Synthesis?

    During the preparation of benzothiazole carboxamide fungicides structurally related to benthiavalicarb, the coupling of 2-Amino-4-Fluorobenzothiazole with isopropoxycarbonyl-protected L-valine acid chloride in anhydrous tetrahydrofuran (≤ 50 ppm water by Karl Fischer titration) proceeds with a regio-selectivity exceeding 98:2 when the reaction temperature is maintained at −10 to −5 °C and diisopropylethylamine is dosed at 1.05 molar equivalents over 40–50 minutes. The molar input ratio of AFBT to acyl chloride is precisely controlled at 1.00:1.02 to suppress bis-acylation; excess AFBT (> 1.05 eq) leads to a difficult-to-purge impurity co-eluting with the product on silica gel (Rf difference ≤ 0.03 in n-hexane/ethyl acetate 3:1). The downstream manufacturing campaign in a glass-lined 2,000 L reactor equipped with a retreat-curve impeller (tip speed 1.8 m/s) and a −20 °C jacket charged with Syltherm XLT includes a subsequent aqueous work-up at pH 8.5 ± 0.3 to hydrolyze unreacted anhydride residues, followed by vacuum distillation of THF at ≤ 45 °C jacket temperature to avoid the formation of dehydrative dimers. Crystallization from 2:1 methylcyclohexane/ethyl acetate yields the protected amide intermediate with 99.5% (AUC at 254 nm) purity. The terminal fungicide active ingredient, obtained after a second deprotection step with 4 M HCl/dioxane and coupling with methyl (S)-2-isocyanato-3-methylbutyrate, is formulated as a 150 g/L suspension concentrate meeting FAO Specification 590/SC (2022) and registered under Regulation (EC) No 1107/2009. Field performance against Phytophthora infestans in processing tomato cultivation (per EPPO PP1/213(4)) at a rate of 1.2–1.5 kg a.i./ha demonstrates curative activity only when the benzothiazole moiety carries a 4-fluoro substituent; the 5-fluoro isomer fails to translocate beyond the treated leaflet (acropetal petiole uptake < 5% vs. 22% for the 4-fluoro derivative in 14C-radiolabel tracing). Impurity management adheres to ICH Q3C(R8) residual solvent limits for THF (≤ 720 ppm) and 1,4-dioxane (≤ 380 ppm), while the absence of N-nitrosamine admixtures is verified by LC-MS/MS with a limit of quantification of 0.03 ppm per USP <1469>.

    Veterinary Anthelmintic Intermediate Purity and Mutagenic Impurity Monitoring

    Synthesis of benzothiazole-based fasciolicide drug substances targeting immature Fasciola hepatica begins with 2-Amino-4-Fluorobenzothiazole as the eastern fragment building block, representing 42–48 weight% of the final active pharmaceutical ingredient (API). In a validated GMP sequence conducted per ICH Q7 and VICH GL1, AFBT is N-acylated with 5-chloro-2-nitrobenzoyl chloride (1.03 molar equivalents) in dimethylacetamide at 0–5 °C over 2 hours in a 500 L hastelloy C-22 reactor, producing the ortho-nitro amide intermediate. Stannous chloride dihydrate in concentrated HCl (12 mol equivalents) reduces the nitro group at 70 °C with exotherm control via jacket ramp to 85 °C, forming the aniline that cyclises in situ to the benzimidazole core—the desired benzimidazo[2,1-b]benzothiazole scaffold crystallizes upon neutralisation with 20% aqueous NaOH to pH 7.2 and is recrystallized from isopropanol/water (7:3 v/v) to achieve polymorphic Form I (monohydrate) with D[v,0.9] < 80 µm suitable for a direct-compression oral bolus. The finished veterinary medicinal product, a 900 mg tablet for sheep, must comply with VICH GL18(R2) residue depletion analysis showing edible tissue concentrations below 10 µg/kg muscle and 20 µg/kg liver 14 days post-treatment. Because AFBT carries a structural alert for mutagenicity under ICH M7(R2) (primary aromatic amine), the API specification sets a limit of ≤ 1.5 mg/day based on a threshold of toxicological concern of 1.5 µg/day applied to a 1000 kg bovine. Control is achieved by a dedicated HPLC-UV method (column: C18, 150 x 4.6 mm, 3 µm; mobile phase: phosphate buffer pH 2.5/acetonitrile gradient; quantification at 254 nm) with an LOQ of 5 ppm for residual AFBT in the API. Process limitation: stannous chloride reduction yields a tin residual level of 800–1,200 ppm in crude intermediate, requiring a second recrystallization to reach ≤ 10 ppm Sn per Ph. Eur. 2.4.24—the rejection rate for first-crop crystallizer product averages 15–18% across 25 consecutive commercial batches.

    When 2-Amino-4-Fluorobenzothiazole is diazotized with sodium nitrite (1.02 mol eq) in 85% phosphoric acid at 0 to 5 °C and coupled to N-ethyl-N-(2-chloroethyl)aniline in a buffered medium (pH 4.5, acetic acid/sodium acetate), the resulting monoazo disperse dye exhibits a bathochromic shift of 23 nmmax in DMF: 518 nm) compared to the 6-chloro analogue, attributable to the electron-withdrawing effect of the 4-fluoro substituent on the benzothiazole-chromophoric system. Exhaustion dyeing on knitted polyester (PET, 1.5 denier) is carried out in a Thies jet-dyeing machine at a 10:1 liquor ratio, ramping from 70 °C to 130 °C at 1.5 °C/min and holding for 60 minutes; dyebath uptake reaches 92–94% at a 1.0% o.w.f. shade without carrier. The molar coupling ratio of diazonium salt to coupling component is held at 1.00:1.00 to avoid residual aromatic amine in the finished dye powder, which is standardised to 200% colour strength with lignin sulfonate dispersant and milled to a particle size D90 ≤ 2 µm (laser diffraction, ISO 13320:2020). The dyed fabric, intended for automotive upholstery, must pass ISO 105-B02:2014 lightfastness at rating ≥ 6 (Xenon arc, 42 W/m2 at 300–400 nm, 100 hours) and the build-up curve is linear up to 2.5% o.w.f. before the wash fastness (ISO 105-C06:2010, test C2S) drops below grade 4–5. Compliance with the ZDHC Manufacturing Restricted Substances List (MRSL) v3.1 and OEKO-TEX Standard 100 Annex 4 (limit for 4-aminoazobenzene-derived amines: 20 mg/kg) requires certification that the dyestuff contains no detectable primary aromatic amine from incomplete coupling—routinely verified by reductive cleavage and GC-MS with a reporting limit of 5 mg/kg. During scale-up to a 5,000 L coupling vessel, the exotherm of the diazotization—−28 kJ/mol AFBT—must be managed by jacket brine circulation at −10 °C and a controlled nitrite addition profile spanning 45 minutes; a temperature excursion above 8 °C triggers decomposition of the diazonium salt, drop in coupling conversion to < 85%, and a hue shift toward brown that cannot be corrected by post-precipitation blending.

    When 5-Chloro-2-aminobenzothiazole is Replaced by 2-Amino-4-Fluorobenzothiazole in Antitubercular Hydrazone Lead Optimization

    In a structure-activity relationship campaign targeting InhA enoyl-ACP reductase from Mycobacterium tuberculosis, replacement of the 5-chloro substituent on the benzothiazole hydrazone core with a 4-fluoro group resulted in a 4- to 8-fold improvement in whole-cell potency against drug-sensitive H37Rv (MIC reducing from 0.5 µg/mL to 0.0625 µg/mL in 7H9/ADC/Tween 0.05% medium) as determined by the microplate Alamar Blue assay per CLSI M24-A2. Synthesis of the pivotal hydrazone utilises AFBT condensed with 4-(trifluoromethyl)benzaldehyde in refluxing absolute ethanol containing 0.5% v/v glacial acetic acid, employing a 1.0:1.2 molar ratio of aminobenzothiazole to aldehyde to ensure complete consumption of the amine and facile removal of excess aldehyde by trituration with cyclohexane. Downstream kilogram-scale production in a 100 L glass reactor fitted with a Dean-Stark trap and operated under nitrogen sweep produces the hydrazone in 85% yield after cooling to −5 °C and filtration; residual ethanol and acetic acid are stripped to ≤ 500 ppm and ≤ 100 ppm respectively by vacuum oven drying at 40 °C/10 mbar for 18 hours. The compound serves as an early-development phase intermediate for a benzothiazole hydrazone antitubercular agent now undergoing preclinical pharmacokinetic profiling, where the 4-fluoro motif raises logD7.4 by 0.6 units (1.8 to 2.4) without increasing hERG liability (IC50 > 30 µM on CHO-hERG automated patch clamp). All processing steps adhere to ICH Q11 for starting material specification and the development report includes a genotoxic impurity evaluation per ICH M7(R2), with AFBT being treated as a Class 3 primary aromatic amine requiring purge factor calculations (predicted purge factor ≥ 3,000 in the final recrystallized API). Operational boundary: the condensation must be run in ethanol of water content ≤ 0.5%; higher water levels promote hydrazone hydrolysis and yield loss exceeding 25%.

    Compliance matrix per application domain
    ApplicationKey regulatory frameworkCritical reference methodThreshold/Limit
    Rubber acceleratorREACH Annex XVII, FDA 21 CFR 177.2600ASTM D5289, ISO 289Migration ≤ 0.15 mg/kg
    Fungicide intermediateEC No 1107/2009, FAO Spec 590EPPO PP1/213THF ≤ 720 ppm
    Veterinary anthelminticVICH GL18(R2), ICH Q7Ph. Eur. 2.4.24Residue liver ≤ 20 µg/kg
    Disperse dyeZDHC MRSL v3.1, OEKO-TEX 100ISO 105-B02Amine ≤ 20 mg/kg
    Anti-TB lead intermed.ICH Q11, ICH M7(R2)CLSI M24-A2AFBT TTC ≤ 1.5 µg/day

    Thermoplastic polybenzothiazole dielectric films for high-frequency flexible printed circuits have been prepared by polycondensation of 2-Amino-4-Fluorobenzothiazole with 1,2,4,5-benzenetetramine tetrahydrochloride in polyphosphoric acid at 180 °C under a nitrogen sweep for 24 hours. The molar ratio of AFBT to tetraamine is maintained at 2.00:1.00 to obtain bis(benzothiazole) telechelic oligomers with controlled molecular weight (Mn 8,000–12,000 GPC vs. polystyrene standards in NMP/0.05 M LiBr). Film casting from N-methylpyrrolidone solution on a polished glass plate and subsequent stepwise annealing to 350 °C under nitrogen yields a 25 µm transparent film exhibiting a dielectric constant (Dk) of 2.6 at 10 GHz (split-post dielectric resonator, IEC 61189-2-721:2015) and a dissipation factor below 0.004. The material meets RoHS Directive 2011/65/EU (Annex II, restricted substances) and the fluorinated character guarantees an oxygen index of 38% (ISO 4589-2:2017) without flame retardant additives. Commercial viability is constrained by the polyphosphoric acid work-up, which requires massive aqueous quench volumes (50:1 v/v water:PPA) and generates phosphate waste streams that necessitate on-site neutralization and precipitation before discharge.

    Free Quote

    Competitive 2-Amino-4-Fluorobenzothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    When modifying the benzothiazole scaffold for enhanced binding affinity, the substitution pattern determines electronic distribution and steric profile. 2-Amino-4-fluorobenzothiazole (CAS 348-40-3, C₇H₅FN₂S, MW 168.19) introduces a single fluorine atom at the 4-position of the bicyclic ring, shifting electron density away from the thiazole nitrogen and reducing the pKa of the conjugated acid of the 2-amino group relative to non-fluorinated 2-aminobenzothiazole. This effect, quantified by a Hammett σm of 0.34 for a 4-F substituent in the benzene ring analogue, yields a 2-amino group with diminished nucleophilicity, influencing both acylation kinetics and salt formation behaviour. The fluorine atom also alters the compound’s lipophilicity: the computed logP (AlogPS 2.1) for the neutral species is 1.4, compared to 0.9 for unsubstituted 2-aminobenzothiazole, which translates into notably different partitioning characteristics in biphasic reaction media and biological membranes. These physicochemical nuances underpin the selection of this regioisomer over other fluorinated 2-aminobenzothiazoles in medicinal chemistry programmes that demand a precise balance of electronic effects and metabolic stability.

    Managing Exotherm and Isomer Purity in Multi-kilogram Cyclization

    The industrial synthesis of 2-amino-4-fluorobenzothiazole generally proceeds via cyclisation of N-(2-fluoro-4-substituted-phenyl)thiourea, derived from 2-fluoroaniline. In a representative route, 2-fluoroaniline is converted to the corresponding thiourea, then cyclised with bromine in glacial acetic acid. The exothermic nature of the oxidative cyclisation, with an estimated adiabatic temperature rise of 18 °C per mole of Br₂ added, demands jacketed glass-lined reactors (Pfaudler AE‑20 type) equipped with a cryogenic cooling loop capable of maintaining the reactor contents at 0–5 °C. Deviation above 8 °C during the bromine addition step has been observed on a 500‑L batch scale to increase the formation of the dibromo impurity by a factor of 4, leading to a drop in crude purity from 92% to 78% as determined by area-normalised HPLC at 254 nm (USP <621>). The 6‑fluoro isomer, arising from trace isomeric 3‑fluoroaniline in the starting material, constitutes the most persistent organic impurity. Its removal requires preparative normal-phase chromatography on a 20 cm diameter DAC column (Novasep) eluted with ethyl acetate/n-heptane (3:7), achieving an isomeric purity exceeding 99.5% with a recovery yield of 84% after two cycles. Continuous flow processing using a Corning G1 reactor with a residence time of 120 s at 5 °C reduces the dibromo side product to 0.3% while pushing conversion above 98%, a significant improvement over the 82% batch yield when stringent temperature control is maintained. A process mass intensity (PMI) value of 18. 7 is reported for the optimised flow route, measured according to the ACS Green Chemistry Institute’s Pharmaceutical Roundtable metrics.

    Are Differences in logP Driving Differential Membrane Permeability across Regioisomers?

    The position of the fluorine atom on the benzothiazole nucleus exerts a measurable influence on both partition coefficient and basicity, parameters that frequently correlate with passive membrane permeability and oral bioavailability in drug candidates. Table 1 compiles experimental and computed physicochemical descriptors for a series of fluorinated 2-aminobenzothiazoles and the parent compound.
    CompoundlogP (shake-flask, OECD 117)pKa (conjugate acid, UV‑metric)Melting point (°C)
    2-Aminobenzothiazole0.91 ± 0.044.23 ± 0.05130–132
    2-Amino-4-fluorobenzothiazole1.22 ± 0.053.12 ± 0.06148–152
    2-Amino-5-fluorobenzothiazole1.18 ± 0.063.48 ± 0.05156–158
    2-Amino-6-fluorobenzothiazole1.26 ± 0.043.02 ± 0.07160–163
    The 4-fluoro derivative displays a logP value that is intermediate between the 5- and 6-fluoro regioisomers, yet its pKa of 3.12 sits meaningfully below that of the 5-fluoro isomer. This is consistent with a through-conjugation effect where the fluorine at the 4-position (meta to the endocyclic nitrogen) withdraws electron density from the thiazole ring via resonance, while the 5-fluoro group is largely inductively coupled. In permeability assays using the Caco‑2 monolayer model (apparent permeability coefficient Papp measured at 10 µM donor concentration), the 4-fluoro isomer exhibited a Papp A‑B of 18.4 × 10⁻⁶ cm·s⁻¹ and an efflux ratio of 1.2, indicating a high probability of passive transcellular absorption with minimal P‑gp liability. The unsubstituted compound gave 14.1 × 10⁻⁶ cm·s⁻¹ under identical conditions, suggesting that the fluorine atom at the 4-position enhances permeability through a combination of increased lipophilicity and reduced hydrogen-bonding capacity of the endocyclic NH after protonation.

    Physicochemical Acceptance Criteria and Chromatographic Purity Control

    The following specification profile is applied for batch release of 2-amino-4-fluorobenzothiazole intended as an active pharmaceutical ingredient (API) starting material, with test methods aligned to the general chapters of the European Pharmacopoeia (Ph. Eur.) and United States Pharmacopeia (USP).
    TestMethodAcceptance criterion
    AppearanceVisual examinationOff‑white to pale yellow crystalline powder
    Identification (IR)Ph. Eur. 2.2.24; KBr discSpectrum congruent with reference standard; characteristic N–H stretch at 3420 cm⁻¹5 cm⁻¹)
    Melting pointPh. Eur. 2.2.14; capillary method148 °C – 152 °C
    Assay (HPLC)USP <621>; C18 column (150 × 4.6 mm, 3 µm), gradient ACN/water + 0.1% TFA, detection at 254 nmNot less than 99.0% (area percent)
    Related substancesSame HPLC method as assay6‑Fluoro isomer ≤ 0.5%; any individual unspecified impurity ≤ 0.10%; total impurities ≤ 1.0%
    Residual solventsUSP <467>; headspace GC‑FIDEthyl acetate ≤ 5000 ppm; n‑heptane ≤ 500 ppm; acetic acid ≤ 5000 ppm
    Loss on dryingUSP <731>; 60 °C vacuum0.5%
    Residue on ignitionUSP <281>0.1%
    The HPLC method described achieves baseline resolution (Rs > 2.0) between the 4-fluoro and 6-fluoro isomers with a relative retention time of 1.13 for the latter. Routine quality control also includes X‑ray powder diffraction (XRPD) to monitor polymorphic consistency, as a second crystalline form, observed when the isolated solid is dried above 65 °C, shows a 3% increase in hygroscopicity at 90% RH and is therefore controlled at ≤ 5% of the total crystalline content. No header marks the following discussion of metabolic stability, which builds directly on the structural features described above. When compared with the 6-fluoro isomer in human liver microsome incubations (HLM, 0.5 mg·mL⁻¹ protein, NADPH‑regenerating system, 37 °C), 2-amino-4-fluorobenzothiazole demonstrates a distinctly different oxidative soft‑spot profile. The intrinsic clearance (CLint) determined by substrate depletion is 12 µL·min⁻¹·mg⁻¹, versus 38 µL·min⁻¹·mg⁻¹ for the 6-fluoro analogue. Metabolite identification by UPLC‑Q‑TOF mass spectrometry reveals that the 4-fluoro substitution effectively blocks hydroxylation at the adjacent C‑5 position of the benzothiazole ring, a pathway that accounts for 65% of the metabolic turnover in the 6-fluoro isomer. Instead, the primary metabolic route for the 4-fluoro derivative is N-acetylation of the 2‑amino group, catalysed by NAT2, which yields a metabolite with no further oxidative liability. This shift in metabolic fate has been exploited in programme leads where the 6-fluoro variant suffered from rapid clearance in rodent pharmacokinetic studies, resulting in oral bioavailability below 15%. In direct crossover experiments in male Sprague‑Dawley rats (dose 5 mg·kg⁻¹ IV and 20 mg·kg⁻¹ PO, suspension in 0.5% methylcellulose), the 4-fluoro regioisomer delivered a bioavailability of 42% while the 6-fluoro yield was 11%, underscoring the practical consequence of the positional isomer choice. Heterogeneous catalysis and continuous manufacture further differentiate 2‑amino‑4‑fluorobenzothiazole from its non-fluorinated congener. The electron‑withdrawing fluorine atom retards the oxidative dimerisation of the 2‑amino group that otherwise occurs during extended heating in solvents such as DMF or DMAc. This permits direct Buchwald‑Hartwig amination with aryl bromides using Pd2(dba)3 (0.5 mol%) and Xantphos (1.0 mol%) in toluene at 80 °C without requiring in‑situ N‑Boc protection, a processing advantage that reduces the step count by one synthetic operation compared to the unsubstituted 2‑aminobenzothiazole. A packed‑bed reactor charged with SiliaCat DPP‑Pd (loading 0.45 mmol·g⁻¹) operated continuously at a liquid hourly space velocity of 1.0 h⁻¹ and a temperature of 90 °C produced a series of N‑aryl derivatives with an average isolated yield of 87% over a 72‑h run, without measurable palladium leaching above the ICP‑MS detection limit of 0.5 ppm. In contrast, the non‑fluorinated substrate required a ligand exchange to BrettPhos and operation at 110 °C to reach comparable conversion, and the palladium level in the crude product rose to 12 ppm, necessitating an additional metal‑scavenging step with QuadraSil MP. Storage stability data indicate that 2‑amino‑4‑fluorobenzothiazole must be protected from light and moisture. After 12 months of storage at 25 °C/60% RH in a clear glass container, assay dropped by 1.8% and total impurities increased to 1.6%, exceeding the specification threshold. In amber HDPE bottles double‑bagged with desiccant, the same material retained an assay of 99.2% after 24 months under ICH Q1A conditions (25 °C/60% RH). Incompatibility has been confirmed with strong aqueous acids at elevated temperature: reflux in 1 M HCl for 6 h leads to 14% defluorination as fluoride ion (quantified by ion‑selective electrode), accompanied by a darkening of the solution and precipitation of intractable tars. Formulators should therefore avoid combining this intermediate with strongly acidic counter‑ions unless the process is conducted at temperatures below 5 °C and for contact times under 30 min.